DAVID SPROUSE: Open Payments
NPI 1528256807 · UNIVERSITY PLACE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 36 payments from 9 companies in 2025. Trend: 2023 $768 · 2024 $620 · 2025 $566
Food & beverage: $557Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $204 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Organon LLC | 5 | $49 |
| Amgen Inc. | 3 | $46 |
| GENZYME CORPORATION | 1 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| Lilly USA, LLC | 2 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, OTEZLA, VTAMA, SPEVIGO, COSENTYX, TALTZ.
Industry payments across WA — which companies pay providers there.
